cladribine

Still hunting a blockbuster, Merck KGaA scores a win in the FDA approval column — more than 13 years in the making
Endpoints
Sun, 03/31/19 - 03:53 pm
FDA
Merck KGaA
cladribine
MA
multiple sclerosis
Analyst sees positive future for Merck KGaA in MS market, as FDA accepts Mavenclad for review
The Pharma Letter
Wed, 08/1/18 - 10:43 am
Merck KGaA
Mavenclad
cladribine
MS
multiple sclerosis
After a long, painful revamp, Merck KGaA scores key OK for once-defunct MS drug cladribine
Endpoints
Fri, 08/25/17 - 09:57 am
Merck KGaA
MS
multiple sclerosis
cladribine
Drug blocked by European regulators improves quality of life for MS patients
Drug Delivery Business News
Fri, 08/18/17 - 12:09 pm
Europe
MS
multiple sclerosis
cladribine
Merck KGaA to try again to get approval for MS pill cladribine
Yahoo/Reuters
Fri, 09/11/15 - 09:57 am
Merck
KGaA
MS
multiple sclerosis
cladribine
With cladribine gone, Gilenya takes center stage
Fierce Pharma
Wed, 06/22/11 - 07:35 pm
Gilenya
cladribine
Movectro
MS
multiple sclerosis
Novartis
Merck KGaA
Merck KGaA Slides After Decision Not to Seek MS Drug Approval
Bloomberg
Wed, 06/22/11 - 08:16 am
MS
multiple sclerosis
Merck KGaA
cladribine
Merck KGaA Drug Fails to Convince FDA
WSJ Online
Wed, 03/2/11 - 11:56 am
Merck KGaA
FDA
cladribine
MS
multiple sclerosis
FDA's Top Q4 Blockbuster Drug Decisions
Fierce Biotech
Tue, 10/12/10 - 11:26 am
Linjeta
Biodel
Afrezza
MannKind
FDA
Benlysta
Human Genome
GSK
Bydureon
Eli Lilly
Amylin
Alkermes
Brilinta
AstraZeneca
Pradaxa
Boehringer Ingelheim
Qnexa
Vivus
Contrave
Orexigen
ipilimumab
Bristol-Myers Squibb
Merck KGaA
cladribine
A Busy Week for Multiple Sclerosis News
Seeking Alpha
Sun, 09/26/10 - 12:24 pm
Novartis
Merck KGaA
Gilenya
multiple sclerosis
cladribine
Biogen Idec
Bayer
Teva Pharmaceuticals
Merck considers appeal of MS drug rejection
Financial Times, UK
Sat, 09/25/10 - 01:11 pm
Merck
multiple sclerosis
cladribine
Merck KGaA's Cladribine Multiple Sclerosis Pill Gets Faster Review in U.S.
Bloomberg
Wed, 07/28/10 - 10:22 am
Merck KGaA
multiple sclerosis
MS
cladribine
Novartis
Gilenia
Merck KGaA expects MS pill to lift drugs margin
Reuters
Wed, 06/30/10 - 10:00 am
Merck KGaA
multiple sclerosis
Gilenia
MS
Merck Serono
cladribine
Merck KGaA again seeks U.S. nod for MS pill
Reuters
Tue, 06/8/10 - 08:37 am
Merck KGaA
multiple sclerosis
MS
cladribine
Merck KGaA Pill Cuts MS Relapse Risk in Half, With Side Effects
Bloomberg
Thu, 04/30/09 - 07:25 am
Merck KGaA
multiple sclerosis
MS
cladribine